The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Grande Alicia since year 2005.
The trader's CIK number is 1402652.
At the time of this reporting, Grande Alicia is the Chief Financial Officer of Catalyst Pharmaceuticals, Inc. .
(stock ticker symbol CPRX).
See this page for all insider trading activities at Catalyst Pharmaceuticals, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-11-06||CPRX||Catalyst Pharmaceuticals, Inc.||Option Ex||200,000||.47||94,000|
|2015-08-25||CPRX||Catalyst Pharmaceuticals, Inc.||Option Ex||40,000||1.09||43,600|
|2014-10-02||CPRX||Catalyst Pharmaceuticals, Inc.||Option Ex||90,000||.90||81,000|
|2012-07-03||CPRX||Catalyst Pharmaceuticals, Inc.||Buy||20,000||.55||10,900|
|2012-05-30||CPRX||Catalyst Pharmaceuticals, Inc.||Buy||17,300||.57||9,861|
|2009-11-19||CPRX||Catalyst Pharmaceuticals, Inc.||Buy||4,200||.65||2,730|
|2009-11-18||CPRX||Catalyst Pharmaceuticals, Inc.||Buy||5,000||.65||3,250|
|2008-11-25||CPRX||Catalyst Pharmaceuticals, Inc.||Buy||2,500||1.85||4,625|
|2008-11-24||CPRX||Catalyst Pharmaceuticals, Inc.||Buy||1,000||1.85||1,850|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Grande Alicia (Chief Financial Officer of Catalyst Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.